Physicians From Around the World Gather in Austin This Week to Learn About Avinger’s Ocelot Technology

OCT-guided catheter can help PAD patients avoid leg amputations and bypass surgeries


AUSTIN, Texas & REDWOOD CITY, Calif.--()--Avinger:

WHAT: IMAGINE 2013 kicks off tomorrow in Austin bringing many of the globe’s top interventional cardiologists and vascular surgeons together to learn about the medical game-changing Ocelot System, a novel technology recently FDA cleared, as well as future applications of OCT-guided therapies. Ocelot gives doctors, for the first time in history, a way to clearly see and navigate inside the tiny leg arteries of their patients that face Peripheral Artery Disease (PAD).

Without Ocelot, bypass surgeries or leg amputations are often the recommended medical solutions for people with PAD, a silent epidemic that impacts 30 million people globally. Ocelot, invented by California medical device company Avinger, has already saved many patients from such dire circumstances. You can see some of their stories here.

Avinger created IMAGINE 2013 to educate the physician population on the benefits of being able to see inside a patient’s artery during the interventional procedure. There will be live patient cases broadcast from Jackson, Mississippi and several insightful panel discussions throughout the week.

WHO: Ocelot’s inventor and Avinger CEO, Dr. John B. Simpson, will host doctors from around the world who are learning to use this first-ever OCT-guided technology from physicians who are experienced with Ocelot. Leading doctors participating include:

  • Mark Picone, Matt Selmon, and Frank Zidar, MDs from the Heart Hospital of Austin in Austin, Texas
  • Gray Bennett, Billy Crowder and Huey McDaniel, MDs from Mississippi Heart and Vascular Institute at St. Dominic's in Jackson, Mississippi
  • Tom Davis, MD from St. John Hospital in Detroit, Michigan
  • Arjun Desai, MD from Stanford University and Clinics in Palo Alto, California
  • Lou Lopez, MD from St. Joseph’s Hospital in Ft. Wayne, Indiana
  • Laiq Raja, MD from El Paso Cardiology Associates in El Paso, Texas
  • Arne Schwindt, MD from St. Franziskus Hospital in Munster, Germany
  • Greg Robertson, MD from Emory Johns Creeks Hospital in Atlanta, Georgia

Wednesday, January 30 - Friday, February 1, 2013

Driskill Hotel
604 Brazos Street
Austin, TX 78701

To learn more about PAD, visit

About Avinger

Founded in 2007 by renowned cardiologist and medical device entrepreneur Dr. John B. Simpson, Avinger develops next-generation catheter-based technologies for the treatment of peripheral artery disease (PAD). Leveraging core competencies in medical device catheter engineering and intravascular Optical Coherence Tomography (OCT), Avinger globally markets Ocelot, the first ever real-time directional OCT crossing catheter, in addition to its Wildcat and Kittycat catheters.


Avinger PR
Deborah Getz, +1 650-241-7900
Press Inquiries:
Mortar PR
Allyson Stinchfield, +1 415-772-9907 ext. 120